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1036MP-127 Mechan isms of  Mitral  Regurg i tat ion  in Aort ic  Stsnos ia :  
Lack of Relationship to Aortic Stenosis Severity and 
Management Implications 
Ramdas G. Psi. Pedmini Varadarajan, VA Medical Center, Loma Lind& California, Loma 
Linda University Loma Lind& California. 
Background: Mitral regurgitation (MR) is common in aortic stenosis (AS) and complicates 
its clinical course and management. It is thought to be related to AS sevedty and dimin- 
ishes with aortic valve replacement for severe AS. However, the response to aortic valve 
replacement alone is vadable and unpredictable. This study investigates into the mecha- 
nisms of MR in patients with AS. 
Methods: Echocerdiographic database search at our institution yielded 650 patients with 
AS - mild (valve area >1.3 cm2) in 399, moderate (valve area 0.8-1.2 cm2) in 154 and 
severe (valve area <0.7cm2) in 97 patients, mean age was 73 + 10 years. 
Results: MR was present in 284 patients - mild in 197, moderate in 63 and severe in 24 
patients. Patients with mild, moderate and severe AS had similar MR grades (p=ns) and 
similar proportion of patients with moderate/severa MR (t3, 14 and 17% respectively, 
p=ns). Presence of moderate/severe MR (n=87) was associated with older age (75+9 vs 
73+9 years, p--O.04), a larger LV end diastolic diameter (57+10 vs 49+8 ram, p<0.0001), 
larger LV end systolic diameter (47_+12 vs 34+9 ram, p<0.0001), lower relative wall thick- 
ness (0.45+0.16 vs 0.54+0.13, p=0.0005), lower LV ejection fraction (37+17 vs 53+14 %, 
p<0.0001), higher degrees of aortic regurgitation (p = 0.03) and left bundle branch block 
(15 vs 5%, p=0.0002) but not with AS severity. Logistic regression analysis identified LV 
ejection fraction and presence of aortic regurgitation to be the independent predictors of 
moderate/severe MR. 
Conclusions: 1)MR is common in patients with AS and is unrelated to AS severity, but is 
associated with larger LV with lesser degree of LV hypertrophy. 2)LV dilatation is central to 
the genesis of MR and should be monitored closely in patients with AS in order to time aor- 
tic valve replacement. 3) Therapies or disease processes that reduce the hypertrophic 
response to AS or cause abnormal intraventdculsr conduction may predispose to MR. 
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1036MP-128 Is Aortic Valve Sclerosis a Manifestation of 
Atherosclerosis? 
Prabhakare S. Heocunie, T. Pratap, Ratnskar Mukherjee, Michael J. Wade, Jignesh S. 
Shah, Paul Kelly, Nasser Khan, VAMC, Syracuse, New York. 
Background: Prior studies have shown that aortic valve sclerosis (AVS) is associated 
with increased cardiovascular events. It has been suggested that AVS is a manifestation 
of stherosclerosis. However, its association with established vascular disease has not 
been studied. 
Methods: We evaluated 154 patients referred to our echocardiography laboratory for cor- 
onary artery disease, peripheral vascular disease and major atherosclerotic dsk factors. 
Patients were considered to have established vascular disease if they had prior coronary 
or peripheral revascularization procedures or documented disease with at least 50% 
stenosis in one or more arteries (coronary or peripheral). All patients underwent 2-D 
echocardiograms, and cardiologists blinded to the clinical information assessed the 
echocardiograms for the presence of AVS. We then compared the prevalence of vascular 
disease between patients with AVS and those with normal aortic valves. 
Results: AVS was diagnosed in 65 patients while 69 patients had normal aortic valves. 
Aortic stenosis (peak systolic gradient > 16 mm Hg) was diagnosed in 20 patients. There 
was no significant difference in the prevalence of documented vascular disease among 
the patients with AVS and those with normal aortic valves (58% vs 48%, p=0,231), 
Patients with AVS were older (mean age 72 years vs 60 years, p=O.0007) and had a 
higher incidence of diabetes (38% vs 22%, p=0.04) compared to patients with normal 
aortic valves. Other atherosclerotic risk factors were evenly distributed between the two 
groups. Even after adjusting for the confounding baseline variables, AVS did not predict a 
higher prevalence of vascular disease (OR=1.19, 0.56-2.52). 
Conclusion: We did not find a significant independent association between AVS and 
established vascular disease in this cross sectional study. Our findings do not support the 
belief that AVS is a manifestation of atherosclerosis. 
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1036MP-129 Aor t i c  Valve Sclerosis, Hemodynsmlcs, and 
Cardiovascular Risk in Hypertension: A LIFE Substudy 
Michael H. Olsen. Kristian Wachtell, Jonathan N. Bella, Vittorio Palmied, Eva Gerdts, 
Markku S. Nieminen, Gunnar Smith, Bj6rn DahlSf, Hans Ibsen, Richard B. Devereux, 
Glostrup University Hospital, Copenhagen, Denmark, Weill Medical College of Come// 
Universi~ New York, New York. 
Background: In population studies aortic valve (AV) sclerosis has been shown to be an 
independent risk factor for cardiovascular morbidity and mortality. We investigated the 
association of aortic valve with abnormalities, hemodynamic parameters and cardiovas- 
cular risk factors in essential hypertension. 
Methods: After two weeks of placebo treatment clinical, laboratory and echo-cerdio- 
graphic variables were assessed in 962 hypertensive patients with electrocardiographic 
left ventricular (LV) hypertrophy without known severe AV stenosis, aged 55-80 (mean 
66±7 years). 
Results: AV sclerosis was found in 389 patients and mild AV stenosis was found in 15 
patients. AV sclerosis was associated with higher LV mass (244 vs. 227 g), higher LV 
mass index (128 vs. 120 g/m2) and older age (68 vs. 65 years, all P<0.001), higher sys- 
tolic blood pressure (175 vs. 173 mmHg, P<O.05), lower serum high density lipopreteins 
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(1.48 vs. 1.55 mmoVI, P<0.05), higher plasma glucose (6.3 vs. 5.8 retool/I, P<0.01). AV 
stenosis was associated with higher relative wall thickness (0.47 vs. 0.41, P<0.001), 
lower circumferential end-systolic stress (157 vs. 183 kdynes/cm2, P<0.05), lower stress 
corrected midwall fractional shortening (89 vs. 97 %, P<0.05), higher pulse pressure/ 
stroke volume (1.24 vs. 1.05 mmHg/ml, P<0.05), lower cardiac output (4.41 vs. 5.24 I/ 
rain, P<0.05), higher total peripheral resistance (2.4 vs. 2.0 kdynes*sec/crn5, P<0.01) 
and older age (71 vs. 65 years, P<0.001). 
Conclusions: AV sclerosis is common in hypertensive patients with electrocardiographic 
LV hypertrophy and associated with other known cardiovascular risk factors such as 
higher LV mass, older age and metabolic abnormalities. AV stenosis was associated with 
concentric geometry, decreased LV contractility, increased vascular stiffness and 
increased total peripheral resistance, but not to metabolic abnormalities. 
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1036MP-130 Exercise Testing Predicts Symptom Onset in Aor t i c  
Stenosls: A Prospective Study of 85 Pat ients  
Paul Das, Helen Rimington, Scott Takeda, Alex Crowther, John Chambers, Guy's and St. 
Thomas' Hospitals, London, United Kingdom. 
Background: The onset of spontaneous ymptoms in aortic stenosis is an indication for 
valve replacement. However, the prognostic value of symptoms induced by exercise test- 
ing is not established in patients who are asymptomatic on clinical assessment. 
Method: We studied 85 patients aged 65 years (range 32-88), 58 male/27 female, of 
whom 36 had severe (effective orifice area (EOA)-<0.acm 2) and 49 moderate stenosis 
(EOA 0.8-1.2cm2). All denied symptoms and had normal left ventdcular systolic function. 
Treadmill exercise testing was performed using the Modified Bruce protocol. A positive 
test was defined by the onset of limiting chest pain, breathlessness or dizziness. Patients 
were followed for 12-65 months and the end-point was the onset of spontaneous ymp- 
toms within 12 months. 
Results: 41 exercise tests (48%) were positive and during follow-up 32 patients (38%) 
developed spontaneous symptoms, 21 (58%) of those with severe and 11 (22%) with 
moderate stenosis. For the whole population, onset of spontaneous symptoms was 
related on univariate analysis to peak transaortic velocity, mean gradient, EOA, mean 
resistance, total exercise time and systolic blood pressure at peak exercise. On multiple 
Iogisitc analysis EOA_<0.acm,2 and a positive test were significant factors (p=0.0001). For 
severe stenosis, the positive and negative predictive values of an exercise test for pre- 
dicting symptom onset were 65% and 54%. For moderate stenosis the positive and neg- 
ative predictive values were 44% and 90%. 
Conclusions: Exercise testing adds prognostic information to effective orifice area. A 
negative test reliably defines a low risk group in patients with moderate aortic stenosis. 
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1060-131 increased Incidence of Surgical Reexploration for 
Postoperative Bleeding Due to Early Postoperative Use 
of Unfractionated Heparin or Enoxaperin 
Heath U. Jones. Joseph B. Muhlestein, Kent W. Jones, Dale G. Renlund, Tami L. Bair, 
Benjamin D. Home, Donald L. Lappe', Donald B. Doty, LDS Hospital, Salt Lake City, 
Utah, University of Utah, Salt Lake City Utah. 
Background: A vadety of indications (e.g., presence of prosthetic heart valves, atdal fibdl- 
lation, ventdcular thrombus, etc.) exist for the use of hepadnoids in the early post-operative 
(post-op) pedod after open-heart surgery. However, the overall post-op risk for hemorrhage 
and the comparative risks between unfrectionatad heparin (UFH) and subcutaneous enox- 
apadn (ENOX) are not known. 
Methods: From 1998 to 2001,2,977 consecutive patients undergoing open-heart coronary 
artery bypass graft or valve surgery were included in this study. Of this group, 2,037 
received no hepadnoid anticoagulation, 579 received intravenous UFH and 361 received 
ENOX at some point dudng their post-op hospitalization. Study outcomes were the need 
for surgical re-exploration for post-op bleeding and the interval between the pdmary sur- 
gery and the first re-exploration. Logistic regression controlled for the covadates of age and 
gender. 
Results: Average patient age was 64+11, 65:t:12, and 68+11 years among those receiving 
no post-op hepadnoid, UFH (p=0.003 vs. none), and ENOX (p<0.001 vs. none), respec- 
tively; and, in those groups, 75%, 63% (p<0.001 vs. none), and 62% (p<0.001 vs. none) 
were male. Rates of surgical re-exploration were 2.7% for no hepadnoid, 7.8% for UFH and 
8.9% for ENOX recipients (Adjusted odds ratio (OR) compared to no bepadnoid = 2.8, 
p<0.001 for UFH and 3.3, P<0.001 for enoxapadn). Females were also at higher risk to 
return (OR=1.5, p=0.02). For those requiring re-exploration, the interval between the pri- 
mary surgery and the first re-exploration was prolonged (_>4 days) among those receiving 
ENOX (37.5%, OR=36.7, p=0.001) and UFH (20%, OR=14.7, p=0.01) compared to none 
(1.8%), and more frequent for ENOX than UFH: OR=2.5, p=0.09. Younger age also tended 
to predict later re-exploration (OR=0.97 per year, p=0.07). 
Conclusion: Post-open heart surgery use of hepadnoid anticoagulants results in a signifi- 
cant increase in the incidence of re-exploration for pest-op bleeding. Enoxapadn appears 
to produce a higher and significantly delayed complication rate compared with UFH. 
